<DOC>
	<DOCNO>NCT01444430</DOCNO>
	<brief_summary>The purpose study evaluate safety Symbicort compare inhaled corticosteroid alone 6 month adult adolescent patient asthma</brief_summary>
	<brief_title>A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only Asthmatic Adults Adolescents</brief_title>
	<detailed_description>A 26 week , randomize , double-blind , parallel-group , active control , multicenter , multinational safety study evaluate risk serious asthma-related event treatment Symbicort® , fix combination inhale corticosteroid ( ICS ) ( budesonide ) long act β2-agonist ( LABA ) ( formoterol ) compare treatment ICS ( budesonide ) alone adult adolescent ( ≥12 year age ) patient asthma .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Provision sign informed consent/ paediatric assent ( applicable ) prior study specific procedure include medication withdrawal Male Female , ≥12 year age Documented clinical diagnosis asthma least 1 year prior Visit 2 Patient must history least 1 asthma exacerbation include one following : require treatment systemic corticosteroid asthmarelated hospitalization 4 week 12 month prior randomization Current Asthma Therapy : Patients must appropriately use one treatment asthma list protocol combine achieve certain result record Asthma Control Questionnaire Patient history lifethreatening asthma . Defined protocol asthma episode require intubation and/or associate hypercapnea require noninvasive ventilatory support . Patient require treatment systemic corticosteroid ( tablet , suspension injectable ) reason within 4 week prior Visit 2 Patient ongoing exacerbation , define worsen asthma require treatment systemic corticosteroid ( tablet , suspension , injectable ) An asthma exacerbation within 4 week randomization 4 separate exacerbation 12 month precede randomization 2 hospitalization treatment asthma 12 month precede randomization Patient respiratory infection viral/bacterial illness , recover illness time Visit 2 , investigator 's opinion , interfere patient 's lung function Patient must meet unstable asthma severity criterion list protocol Peak expiratory flow must 50 % predict normal Pregnancy , breastfeed plan pregnancy study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>130 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Symbicort pMDI</keyword>
	<keyword>Asthma</keyword>
	<keyword>safety</keyword>
	<keyword>budesonide</keyword>
</DOC>